Funded Health Care Startups in Tel Aviv
Among the 10 most recent Health Care funding events in Tel Aviv, one disclosed round stands far above the rest: Medigate’s $30M (2020-09-15).
Among the 10 most recent Health Care funding events in Tel Aviv, one disclosed round stands far above the rest: Medigate’s $30M (2020-09-15). The next-largest disclosed amounts cluster below that level, including Alpha Tau Medical’s $26M (2020-06-04) and NeuraLight’s $25M (2022-05-24), while multiple other entries sit at $18M (Envizion Medical, 2020-09-03), $17M (Circles - Online Group Support, 2022-05-24), and $15M (Laguna Health, 2023-05-16; Fairtility, 2022-05-23).
The disclosed results are also temporally clustered into two main windows: five rows fall in mid-2022 to mid-2023 (from 2022-05-23/24 through 2023-07-14), and three more fall in September–June 2020 (2020-06-04, 2020-09-03, 2020-09-15). Disclosures skew toward “Series Unknown” or undisclosed amounts, with 4 of 10 labeled as Series Unknown (QuantHealth 2025-09-30; Agado 2023-07-25; Galmed Pharmaceuticals 2023-07-14) and 2 additional entries showing undisclosed amounts (QuantHealth and Agado).
Most recent rounds
10 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Tel Aviv Health Care set, and how does it compare to the other disclosed amounts?
Medigate’s disclosed $30M (2020-09-15) is the top figure. The next-largest disclosed rounds are $26M (Alpha Tau Medical, 2020-06-04) and $25M (NeuraLight, 2022-05-24), with several other disclosed rounds at $18M, $17M, and $15M.
Do the funding dates cluster into specific windows among the 10 most recent rows?
Yes. Five rows land between 2022-05-23/24 and 2023-07-14 (Fairtility 2022-05-23; Circles 2022-05-24; NeuraLight 2022-05-24; Laguna 2023-05-16; Galmed Pharmaceuticals 2023-07-14), while three rows concentrate in 2020 around June/September (Alpha Tau Medical 2020-06-04; Envizion Medical 2020-09-03; Medigate 2020-09-15).
How much of the list has undisclosed or “Series Unknown” disclosures, and does that align with the largest disclosed figure?
Four of the 10 entries are labeled “Series Unknown” (QuantHealth 2025-09-30; Agado 2023-07-25; Galmed Pharmaceuticals 2023-07-14; and the 2020 entries Medigate/Envizion/Alpha Tau show blank stage). Two entries are explicitly “undisclosed” on amount (QuantHealth and Agado, both undisclosed). The largest disclosed amount ($30M by Medigate on 2020-09-15) sits outside the explicitly “undisclosed” amounts.
What stage labels appear most often, based on the rows shown?
“Series A” appears 4 times: Laguna Health ($15M, 2023-05-16), Circles - Online Group Support ($17M, 2022-05-24), NeuraLight ($25M, 2022-05-24), and Fairtility ($15M, 2022-05-23). By contrast, 1 row is explicitly tagged “Series Unknown” with an undisclosed amount (QuantHealth, 2025-09-30), and multiple rows have blank stage labels (Medigate 2020-09-15; Envizion Medical 2020-09-03; Alpha Tau Medical 2020-06-04).
Are there any amount outliers worth a closer look beyond the top disclosed round?
Aside from Medigate’s $30M (2020-09-15), the remaining disclosed amounts run from $7M (Galmed Pharmaceuticals, 2023-07-14) up to $26M (Alpha Tau Medical, 2020-06-04), with no other single disclosed figure approaching $30M. The $7M entry is the smallest disclosed amount in the rows shown, creating a clear low-end boundary compared with $15M+ rounds like Laguna Health (2023-05-16, $15M) and Circles (2022-05-24, $17M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.